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Abstract
Background and Purpose: The Four Square Step Test (4SST), a quick and simple test of multidirectional stepping, may be useful in predicting falls in people with Parkinson disease (PD). We
studied the reliability of the 4SST and its ability to discriminate between freezers and nonfreezers, fallers and non-fallers, and factors predictive of 4SST performance in people with PD.
Methods: Fifty-three individuals with idiopathic PD completed the full protocol including the
4SST as well as measures of balance, walking, and disease severity on anti-PD medication.
Results: Inter-rater (ICC = .99) and test-retest reliability were high (ICC = .78). The median
4SST performance was 9.52 seconds. There was a significant difference between 4SST time on
medication versus off (p=.03), while differences between fallers/non-fallers (p=.06) and
freezers/non-freezers (p=.08) did not reach significance. All outcome measures were
significantly related to 4SST time. In an exploratory, simultaneous regression analysis 56% of
the variance in 4SST performance could be accounted for by three measures: Mini-BESTest,
Five Time Sit to Stand, and Nine Hole Peg Test. The 4SST cutoff score for distinguishing fallers
from non-fallers was 9.68 seconds (AUC = .65, sensitivity = .73, specificity = .57). The post-test
probability of an individual with a score above the cutoff being a faller was 31% (pre-test
probability = 21%).
Discussion and Conclusion: The 4SST is a reliable, quick test that can distinguish between on
and off medication conditions in PD, but is not as good as other tests (e.g. Mini-BESTest) for
distinguishing between fallers and non-fallers.
Key words: Four Square Step Test, Parkinson disease, fall risk, balance

Introduction
The progressive nature of Parkinson disease (PD) leads to significant movement-related
impairments.1 Gait difficulty, including freezing of gait, and postural instability are common
among people with PD and are highly associated with falls.2,3 Falls occur in up to 70% of
individuals with PD, with potential sequelae including mobility restrictions, fractures, and
mortality.4-7 Injuries related to falls significantly increase medical costs for those with PD.8
Given the devastating effects of falls, it is critical that individuals at risk for falls be accurately
identified so that they can receive interventions directed at improving gait and balance and
reducing fall risk.
Previous research shows that the best predictor of falls is a prior history of falls,9 but this
relies on accurate self-report of past events. It is preferable for clinicians to be able to directly
measure a person’s performance in order to evaluate fall risk. Recent work suggests that some
clinical balance tests such as the Balance Evaluation Systems Test (BESTest) and Mini-BESTest
may be useful for identifying those who will fall in the next six months.10 However, these and
other clinical balance tests are often time consuming and therefore may be impractical to use on
a regular basis. As such, investigation of the clinical utility and predictive value of quick and
easy-to-administer clinical tests is warranted.
The Four Square Step Test (4SST), first described by Dite and Temple, is a quick and
simple clinical test that requires an individual to rapidly step over obstacles in the forward,
backward, and sideways directions.11 We hypothesized that the 4SST may be a useful balance
screen in people with PD for the following reasons: a) it demands complex anticipatory postural
adjustments for gait initiation, known to be impaired in people with PD,12-15 b) the requirements

for stepping backward and laterally may be particularly challenging for people with PD,16,17 and
c) the task requires execution of a complex multi-step movement sequence, another area of
known difficulty in PD.18-20 To our knowledge, no study to date has evaluated 4SST
performance in people with PD. However, 4SST performance has been studied in older adult
fallers and non-fallers, individuals with stroke, and individuals with a vestibular disorder.11,21,22
The purpose of this study was to evaluate 4SST performance in individuals with PD. We
aimed to:1) establish inter-rater and test-retest reliability of the 4SST in PD, 2) determine the
effectiveness of the 4SST in distinguishing between on and off anti-PD medication conditions,
fallers and non-fallers, and freezers and non-freezers, and 3) describe factors related to and
predictive of 4SST performance in PD. We hypothesized that the 4SST would possess high interrater and test-retest reliability, correctly distinguish between on and off anti-PD medication
conditions, fallers and non-fallers, and freezers and non-freezers, and be related to balance,
bradykinesia, and freezing of gait in people with PD.

Methods
Participants
Individuals over age forty with idiopathic PD who were already participating in two
separate, ongoing studies were consecutively recruited.23,24 Participants included in the study
must have been diagnosed with “definite” PD, as defined by Racette and colleagues.25 Potential
participants were screened and excluded if found to have any of the following: 1) a serious
medical condition, 2) history or presence of a neurological condition other than PD, 3) previous
surgical management of PD (e.g. deep brain stimulation), or 4) a musculoskeletal injury that

considerably inhibited movement. All participants provided written informed consent to
participate in the protocol as approved by the Human Research Protection Office of XXXXXX.
Fifty-three individuals (58% male) with idiopathic PD were included in the study. Each
participant reported fall history over the past six months and based on this was classified as a
faller if he reported more than one fall in that period of time. Participants reporting no falls or
only one fall in the previous six months were classified as non-fallers. Participants also
completed the Freezing of Gait Questionnaire (FOG-Q), a self-assessment of walking
performance during their self-perceived worst state, how gait impairments impact functional
independence, whether or not freezing is experienced, and characteristics of freezing episodes.26
A participant was classified as a freezer if he or she gave a rating greater than one on item three
of the FOG-Q, indicating FOG episodes occurring at least once per week. One participant was
excluded due to an inability to step in the backward direction secondary to freezing.
Demographic information is presented in Table 1. Twenty-eight participants (54% male), a
subgroup of the original sample, were chosen to complete the 4SST on and off anti-PD
medication to determine if the 4SST possessed the ability to distinguish between medication
conditions.
INSERT TABLE 1 HERE
Outcome Measures
4SST
Performance of this test was carried out as originally described by Dite and Temple.11
Meter sticks, set up to appear like a crosshair, were used as the obstacles over which participants
would step (Figure 1). These meter sticks were not fixed to the surface. Participants faced the

same direction when stepping to the different squares, and both feet had to touch each square
before the next movement. Stepping was completed in the following sequence: forward, right,
backward, left, right, forward, left, backward. Timing began when the first foot hit the second
square and stopped when the last foot returned to the final square. Successful completion of a
trial was a trial in which the meter sticks were not touched during performance of the test. The
4SST has been shown to have high inter-rater and test-retest reliability among the elderly and
individuals with vestibular disorders.11,22
Movement Disorders Society - Unified Parkinson Disease Rating Scale – III (MDS-UPRDS-III)
Motor symptom severity was assessed using the MDS-UPDRS-III.27 From this
assessment, we also determined the H&Y stage of each participant. The MDS-UPDRS-III was
administered by a physical therapist (RPD) who was trained using the official MDS-UPDRS
training video.28
Mini-Balance Evaluations Systems Test (Mini-BESTest)
The Mini-BESTest is an instrument used to assess balance through evaluation of postural
stability during performance of 14 dynamic tasks.29 Investigators have previously demonstrated
high inter-rater and test-retest reliability when using the Mini-BESTest to evaluate balance in
individuals with PD.30
Five Times Sit to Stand (FTSTS) Test
Because there was potential that the 4SST and FTSTS test may be measuring similar
constructs, the FTSTS was included in the assessment battery. The FTSTS test measures how
quickly one can go from sitting to standing five consecutive times without using the upper

extremities. Balance and bradykinesia are predictive of FTSTS performance in PD.31 This test
has also been shown to have high inter-rater and test-retest reliability in PD.31
Six Minute Walk Test (6MWT)
Endurance was measured using the 6MWT, which has been shown to be highly reliable
when assessing people with PD.32 Participants were asked to cover as much ground as they could
in six minutes while walking, and if necessary, assistive devices were used. Distance covered
was measured to the nearest meter.
Nine Hole Peg Test (9HPT)
The 9HPT was used as a measure of bradykinesia.33,34 Participants were instructed to
place nine pegs into nine holes, one at a time, as quickly as possible. The non-dominant hand
was used to stabilize the peg board if necessary. Two trials were completed using the dominant
hand, and the mean of these two trials was calculated. This test is highly reliable when
examining upper extremity function in people with PD.33
Procedures
All outcome measures were assessed while participants were on anti-PD medication. In
addition, a subset (n=28) of this group who were those recruited for one of the two studies
mentioned previously was also tested while off anti-PD medication. Participants were considered
off medication if the last medication dose was administered greater than 12 hours prior to
evaluation. A physical therapist instructed participants in correct performance of the 4SST.
Following instruction, one untimed practice trial and two timed trials of the 4SST were
completed. Two raters timed the trials. Inter-rater reliability was determined comparing the times

recorded by the two raters for the first trial performed, while test-retest reliability was
determined comparing the times of the first and second trials collected by the primary rater.
Because it was our aim to determine if 4SST performance could be distinguished between off
and on medication states, only 4SST times were obtained in the off medication state. After
completing off medication testing, participants were allowed to take their normal dose of anti-PD
medication. For participants on medication, we administered the measures in the following order:
MDS-UPDRS-III, 4SST, Mini-BESTest, FTSTS test, 9HPT, FOG-Q, and 6MWT. All outcome
measures were administered by the same rater.
Data Analysis
Descriptive statistics were calculated using only the first trial of the 4SST because this
was deemed most clinically relevant by the authors. Intraclass correlation coefficients were used
to describe inter-rater (ICC 1,1) and test-retest (ICC 2,1) reliability of the 4SST. For all analyses
beyond reliability and the off/on medication comparison, only the first timed trial of the 4SST
performed on medication was used. Because 4SST times were not normally distributed we used
nonparametric statistics to examine differences between conditions or groups. To determine
differences between off and on medication 4SST times, we used a Wilcoxon Signed Rank test.
To determine if there were differences in 4SST performance between fallers and non-fallers and
freezers and non-freezers we used Mann Whitney U tests. Spearman correlation coefficients
were used to describe relationships between the 4SST and all other outcome measures. Statistical
significance for analyses was set at α ≤ .05. Outcome measures that were significantly correlated
with the 4SST were entered into an exploratory, simultaneous regression model to determine
factors predictive of 4SST performance. In cases of multicolinearity, the variable with the
highest correlation with the 4SST was retained and the collinear variable was removed from the

analysis. In the final model, only those factors that significantly contributed (p<0.05) were
retained. Finally, a cutoff score for 4SST performance in fallers versus non-fallers was
determined using ROC curves. This cutoff score was chosen based on the minimum value of: (1sensitivity)2 + (1-specificity)2.35 From this cutoff score, positive (LR+) and negative (LR-)
likelihood ratios, pre-test and post-test probabilities were calculated. The ROC curve of the 4SST
was compared to that of the Mini-BESTest for this sample. Data analysis was conducted using
NCSS software version 7.1.19 (NCSS Software, Kaysville, UT).

Results
Inter-rater reliability, tested only on medication, was high (ICC = .99). Test-retest
reliability was high when testing participants both off (ICC = .90) and on (ICC = .78)
medication.
The median 4SST performance time on medication was 9.52 (95% LCL-UCL: 9.03 –
10.54) seconds (Table 2). Figure 2 shows the frequency distribution for 4SST scores on
medication for the full sample, with 4SST times binned into one second intervals. 4SST
performance was significantly different off compared to on medication (p = .03). There were no
significant differences in 4SST performance between freezers and non-freezers (p = .08) and
between fallers and non-fallers (p = .06) (Table 2). All outcome measures were significantly
related to 4SST performance on medication (Table 3), most notably the Mini-BESTest, MDSUPDRS-III, age, 9HPT, and FTSTS.
INSERT FIGURE 1 HERE
INSERT TABLE 2 HERE

INSERT TABLE 3 HERE
Age, MDS-UPDRS-III, Mini-BESTest, FTSTS, 9HPT, FOGQ, and 6MWT were all
entered into a simultaneous regression model, as all of these factors were significantly correlated
with 4SST performance. However, due to issues with multicolinearity with the Mini-BESTest,
age and MDS-UPDRS-III were removed from the model. Of the remaining five variables
entered, only three contributed significantly to the model. Thus, the final model included only
the Mini-BESTest, 9HPT and FTSTS as shown in Table 4. This model explained 56% of the
variance in 4SST performance.
INSERT TABLE 4 HERE
Figure 3 displays the ROC curves of the 4SST and the Mini-BESTest for discriminating
between fallers and non-fallers. The AUC for the 4SST was 0.65 (95% CI: 0.43-0.80) compared
to an AUC of 0.80 for the Mini-BESTest. Maximizing sensitivity and specificity, the cutoff
score for the 4SST was determined to be 9.68 seconds (sensitivity = .73, specificity = .57).
Forty-seven percent of our sample scored above this cutoff. The positive and negative likelihood
ratios for those scoring above the cutoff were 1.7 (95% CI: 1.00-2.73) and 0.48 (95% CI: 0.171.27), respectively. The post-test probability of a fall for those with scores above the cutoff was
31%, compared to a 21% pre-test probability.
INSERT FIGURE 2 HERE

Discussion
To our knowledge, this is the first study to describe 4SST performance in people with
PD. According to our results, there is high inter-rater and test-retest reliability for the 4SST when

testing individuals with PD on and off anti-PD medication. Secondly, people with PD perform
the 4SST more slowly off medication than they do when on medication; however, there was no
difference in 4SST performance for freezers/non-freezers and fallers/non-fallers. Finally, all
measures employed were significantly correlated with 4SST performance. Measures reflective of
balance and bradykinesia combined to explain 56% of the variance in 4SST performance in
people with PD.
Inter-rater reliability (ICC = .99), when testing individuals with PD on anti-PD
medication, matches that noted by Dite and Temple in the original description of the 4SST.11 The
test-retest reliability when testing people on medication (ICC = .78) was lower than expected.
While the designs for assessing test-retest reliability were similar, Whitney and colleagues
reported much higher reliability (ICC = .93) when testing individuals with a vestibular disorder.
In our study, it is possible that a practice effect could have led to consecutive improvements in
4SST performance times from the practice trial and then to the first and second trials, lowering
agreement between 4SST times. Because we were limited in our ability to have the participants
return for a follow-up visit, we could not capture test-retest reliability with more than one or two
minutes between trials.
On medication, the median time taken by our full sample to complete the 4SST was 9.52
seconds, which is faster than that of healthy older individuals who had at least one fall in the
previous six months, individuals post-stroke, and individuals with a vestibular disorder.11,21,22 It
is particularly interesting that on average our group with PD was faster than healthy older
individuals who had at least one fall in the previous six months. This difference could be related
to the fact that this sample with a history of at least one fall was heterogeneous due to inclusion
of individuals with varied histories such as stroke, cardiovascular disorders, and neurologic

disorders.11 4SST performance in PD may also be enhanced by the visual cues provided by the
apparatus used for the test. Investigators have shown that visual cues improve gait initiation in
the forward direction.36 We speculate that these cues may also translate to improved stepping in
the backward and lateral directions and as such the grid used for the 4SST may provide visual
cues that enhance performance of stepping during the test. However, it is important to note that
Dite and Temple reported that a group of 27 healthy older adults, a homogenous sample without
co-morbidities or history of falls, had a mean 4SST time of 8.70 seconds.11 This suggests that
while the meter sticks may have improved performance for those with PD, there is still evidence
of impairment relative to healthy controls.
Foreman and colleagues stated that there is a need for clinical balance tests that are
“responsive to changes in performance within individuals (medication status) and responsive to
differences between individuals (e.g. fallers versus non-fallers) (p169).”37 We studied the
responsiveness of the 4SST to changes in medication status in those with PD, in addition to the
responsiveness to differences between freezers and non-freezers and fallers and non-fallers with
PD. The results of this study also indicate that people with PD demonstrate different 4SST
performance when off anti-PD medication compared to on. We found improved 4SST
performance while on medication, a finding in accordance with Morris and colleagues who
found improved Timed Up and Go performance on medication versus off.38 In our sample, the
4SST did not distinguish between fallers and non-fallers and freezers or non-freezers. This may
be related to our relatively small sample sizes of fallers and freezers which reduces our power to
detect differences.
Our results demonstrated that all measures employed in this study were significantly
related to 4SST performance in people with PD. Most notably, the Mini-BESTest score

demonstrated a significant moderate correlation to 4SST performance. This is not surprising as
good balance is necessary to complete the multi-directional stepping test in a timely fashion. The
other correlation worth noting is the significant relationship between the 9HPT and 4SST.
Earhart and colleagues noted that bradykinesia was a significant predictor of 9HPT performance
time in people with PD.33 Due to the relationship between the 9HPT and 4SST, we suspect that
bradykinesia might also be influencing 4SST performance in this population. We also noted that
the Mini-BESTest, 9HPT and FTSTS combined to explain 56% of the variance in 4SST
performance. This is very similar to results reported by Duncan et al., who studied factors
predictive of FTSTS performance in people with PD.31 Because both the 4SST and FTSTS are
timed tests of mobility, the results noted by Duncan et al. and those reported in this study suggest
that balance and bradykinesia play significant roles in timed tests of mobility in people with PD.
Regarding the detection of fallers, the 4SST demonstrated moderate levels of sensitivity
(.78) and specificity (.57) with a cutoff time of 9.68 seconds. A 4SST time above the cutoff does
not immediately suggest that the person with PD is at significant risk for falls. This notion is
supported by the fact that when an individual with PD completes the 4SST in more than 9.68
seconds (LR+ = 1.7), the post-test probability of being a faller is 31% compared to a pre-test
probability of 21%. A 4SST completion time less than the cutoff (LR- = .48) yields a post-test
probability of 11%. Based on our analysis, it is evident that the Mini-BESTest outperforms the
4SST in identifying fallers and non-fallers with PD. Leddy and colleagues demonstrated that the
Mini-BESTest (sensitivity = .88, specificity = .78) and BESTest (sensitivity = .84, specificity =
.76) had better predictive ability than that of the 4SST in the present study.30 These findings were
echoed in a prospective study of fall risk in PD in which the Mini-BESTest (sensitivity = .86,
specificity = .78) and BESTest (sensitivity = .93, specificity = .84) outperformed other balance

measures when identifying fallers six months after assessment.10 While the 4SST is similar in its
predictive abilities to other quick tests of motor function, the 4SST should not replace more
extensive balance testing when attempting to determine fall risk in people with PD.31,37
The results of the present study should be interpreted in light of several limitations. First,
this pilot study included a small sample size of people with mild to moderate PD among which
there were small numbers of fallers and freezers. The results demonstrating that the fallers and
freezers performed the 4SST more slowly than non-fallers and non-freezer, respectively, should
be interpreted with caution. Second, all analyses other than test-retest reliability utilized our
analyses utilized only one timed trial of the 4SST. This was done in order to reflect the clinical
practice of rehabilitation professionals where it is likely that only one trial of the 4SST would be
collected. However, somewhat different results may have been obtained if the results of several
trials had been averaged. Finally, we measured test-retest reliability with only minutes between
4SST trials and recommend that investigators measure test-retest reliability of the 4SST in
people with PD with perhaps days or a week between administrations of the test. In the future,
investigators should study the 4SST’s responsiveness to change over time or after intervention
and may also consider examining the combined ability of the 4SST and other quick tests of
motor function in predicting who will fall with PD.

Conclusion
The 4SST, when used in people with PD, is able to distinguish between off and on antiPD medication states, but not between freezers and non-freezers and fallers and non-fallers.
Mini-BESTest, 9HPT, and FTSTS scores were most predictive of 4SST performance. Because of

its limited ability in accurately predicting falls in those with PD, we do not recommend use of the
4SST in lieu of other balance measures such as the Mini-BESTest.
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Table 1. Demographic information of participants.

Table 2. 4SST performance times (group comparisons)

Table 3. Spearman correlations of outcome measures with 4SST.

Table 4. Final Regression Model for 4SST
4SST

B

SE B

β

p

FTSTS
Mini-BESTest
9HPT

0.07
-0.31
0.09

0.03
0.08
0.04

0.23
-0.46
0.25

0.04
0.0001
0.02

R2 When
Fit Alone
0.26
0.45
0.26

Partial R2
0.09
0.26
0.10

Cumulative
R2
0.26
0.51
0.56

Figure 1. Diagram illustrating the setup utilized for the 4SST. Four separate meter
sticks (light gray) were arranged on the floor as shown. Arrows illustrate directions of
stepping forward, lateral, and bacward to complete a full circuit first in the clockwise
(black, numbers 1-4) and then in the counterclockwise (dark gray, numbers 5-8)
direction.

Figure 2. Frequency histogram showing distribution of 4SST times for the full sample
when tested on medication. Times are grouped into one second bins.

Figure 3. ROC curves of the 4SST and Mini-BESTest.

